Are you 65 years of age or older and interested in participating in a clinical study evaluating a new therapy designed to enhance your natural immunity? The RESILIENCE study is assessing the effectiveness of a new therapy in improving natural immune function and reducing respiratory tract infections in adults 65 years of age or older. What does the study involve? • Injection given through a small needle under the skin. 3 times a week for 16 weeks. • Blood collection 8 times over a period of a year. To learn more, please contact Email: info@isstudy.ca Phone: 1-877-223-8637 Or visit www.qubiologics.com/clinical-trials/resiliencestudy